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Caffeine reduces hepatic lipid accumulation
through regulation of lipogenesis and ER
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Abstract
Background: Caffeine, the main component of coffee, has showed its protective effect on non-alcoholic fatty liver
disease (NAFLD) in many studies. However, the hepatoprotection of caffeine and its mechanisms in zebrafish were
unexplored. Thus, this study’s intentions are to establish a NAFLD model of zebrafish larvae and to examine the role
of caffeine on fatty liver with the model.
Results: Growth and the incidence of fatty liver of zebrafish larvae increased with the increased amount of feeding
in a dose-dependent manner. The degree of hepatic steatosis of larvae also gradually aggravated with the
increased quantity and duration of feeding. Triglyceride contents of zebrafish fed for 20 days significantly increased
in model group (180 mg/d) compared with control group (30 mg/d) (P < 0.001). Significant decreases in body
weight and hepatic steatosis rate were observed in 2.5, 5, 8 % caffeine treatment group compared with model
group (P < 0.05). Hepatic lipid accumulation was also significantly reduced in caffeine treatment larvae. Moreover,
caffeine treatment was associated with upregulation of lipid β-oxidation gene ACO and downregulation of
lipogenesis-associated genes (SREBP1, ACC1, CD36 and UCP2), ER stress-associated genes (PERK, IRE1, ATF6 and BIP),
the inflammatory cytokine genes (IL-1beta and TNF-alpha) and autophagy associated genes (ATG12 and Beclin-1).
Protein expression of CHOP, BIP and IL-1beta remarkably reduced in caffeine treatment group compared with
model group.
Conclusions: We induced hepatoteatosis in zebrafish by overfeeding regimen and demonstrated caffeine have a
role in suppression of hepatosteatosis by downregulation of genes associated with lipogenesis, ER stress,
inflammatory response and enhancement of lipid oxidation, indicating zebrafish model may be used to identify
putative pharmacological targets and to test novel drugs for human NAFLD treatment.
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Background
NAFLD is becoming one of the most common causes of
chronic liver diseases. It is estimated that approximately
20–30 % of adults and 3–10 % of children in western
countries suffer from excessive fat accumulation in the
liver [1]. Following the prevalence of obesity and its asso-
ciated complications such as diabetes, insulin resistance
and hyperlipidemia in the world, the incidence of NAFLD
have been increasing in recent years. Indeed, NAFLD is
considered to be a manifestation of metabolic syndrome
in the liver [2, 3], which range from non-progressive sim-
ple steatosis to non-alcoholic steatohepatitis (NASH) with
ballooning degeneration, inflammation and fibrosis.
NASH can progress from steatohepatitis to liver cirrhosis,
and may eventually develop hepatocellular carcinoma
after decade years.
There are many studies that have attempted to establish
NAFLD models in rodents via the use of dietary [4, 5] and
pharmacological [6] induction, as well as genetic manipu-
lation [7, 8]. Recently, zebrafish compare popularly to
rodents as new experimental animals for researchers be-
cause zebrafish have a high reproductive rate, mature rap-
idly, and cost little regard to rearing space and daily
* Correspondence: liliu.fimmu@gmail.com; jlhousmu@163.com
1State Key Laboratory of Organ Failure Research, Guangdong Provincial Key
Laboratory of Viral Hepatitis Research, Department of Infectious Diseases,
Nanfang Hospital, Southern Medical University, Guangzhou 510515, China
Full list of author information is available at the end of the article
© 2015 Zheng et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Zheng et al. Journal of Biomedical Science  (2015) 22:105 
DOI 10.1186/s12929-015-0206-3
maintenance due to their small size. More and more re-
searchers use zebrafish as a model to study the pathogen-
esis and pharmacological therapy of NAFLD. In a review,
Yoichi Asaoka et al. [9] summarized the various types of
fish models in use for NAFLD, including those generated
by mutation [10], transgenesis [11–15], or dietary [16, 17]
or chemical [18, 19] treatment, and contrast them with ro-
dent models. And recently Valerie Sapp et al. [20] have
established a fructose-induced zebrafish model of NASH
in 7 days post-fertilization (dpf) zebrafish larvae. However,
these previous study for NAFLD using zebrafish model
mostly focused on the period of 5dpf-7dpf zebrafish larvae
and adult zebrafish, there is lack of knowledge about
studying juvenile zebrafish larvae of NAFLD. Because of
the advantage of transparent body in juvenile period suit-
able for identifying lipid accumulation in liver by whole-
mount oil red O staining, in present study we attempted
to determine whether juvenile zebrafish can be used as a
model for diet-induced NAFLD.
Coffee is probably the most frequently consumed bev-
erage worldwide. Because of its consumption in most
countries in the world, it is concerned to investigate its
potential benefits or adverse aspects in relationship to
human health in terms of a public and a scientific
perspective. Caffeine is a main component of coffee,
which also includes other ingredients such as diterphe-
noic alcohols, potassium, niacin, magnesium, and the
anti-oxidants chlorogenic acid (CGA) and tocopherols.
Although coffee and caffeine can increase the risk of car-
diovascular disease, numerous evidences demonstrated
that coffee and caffeine have a hepatoprotective effect
on chronic liver diseases [21, 22]. Epidemiological and
clinical investigations have suggested that its consump-
tion could reduce the risk of alcoholic liver cirrhosis
[23], type 2 diabetes [24–26], NAFLD [27–29], and HCC
[30–33] and the progression of NASH and the severity
of fibrosis [34], as well as the activity of ALT in liver in-
jury patients [35]. There are many studies that show cof-
fee and caffeine exhibit a beneficial role on liver injury
in animal and in vitro studies. Sandra kal thoff et al. have
demonstrated that coffee mediate the protective and
antioxidant properties through upregulation of expres-
sion of glucuronosyltransferases in liver and stomach
[36]. Experimental study has shown that caffeine can at-
tenuate the development of liver cirrhosis and HCC
through inhibition of transforming growth factor-beta
(TGF-beta) and its downstream effectors [37]. Recent
study has demonstrated that caffeine reduces intrahepa-
tic lipid content and stimulates β-oxidation in hepatic
cells and liver by an autophagy-lysosomal pathway via
using genetic, pharmacological, and metabolomic ap-
proaches [38]. Similarly, researchers have shown that
caffeine effectively depletes TG and cholesterol levels by
inhibition of lipogenesis and stimulation of lipolysis
through modulating AMPK-SREBP signalling pathways
in HepG2 cells [39]. While coffee and caffeine show a
hepatoprotective characteristic on NAFLD, the precise
mechanism is completely unknown.
In this study, we determined the effect of caffeine on
lipid accumulation in the liver of zebrafish larvae by
establishment of diet-induced model of NAFLD in
juvenile zebrafish. We have developed a zebrafish model
for NAFLD and confirmed the model by morphological,
chemical and histological analyses. Our results shown
that caffeine can reduce hepatic lipid accumulation in
diet-induced zebrafish, which probably exerts antisteato-
tic effect through reduced input of fatty acid and inhib-
ition of lipogenesis and improvement of ER function,
and attenuation of inflammation response.
Methods
Feeding zebrafish
Wild-type zebrafish (Danio rerio) were raised and
cared for as per standard procedures in accordance
with a protocol approved by the Southern Medical
University Animal Care and Use Committee. Embryos
and larvae were reared in embryo medium at 28 °C to
5 dpf. Zebrafish larvae with completely development
from a single cluster at 5dpf were allocated randomly
to a serial of different amount of feeding groups:
20 mg/d, 30 mg/d, 60 mg/d, 80 mg/d, 120 mg/d and
180 mg/d. Each group had 100 larvae and started to
feed at 7 dpf for 10, 15 and 20 days in 1.5 L tanks after
adaptive of deep water environment for one day. They
were fed a larval food (Zeigler AP100) three times
daily, which was grinded to powder until food can
float on the face of water, and then exchanged by half
water after fed for 2 h. For caffeine treatment, larvae
were overfed with 1, 2.5, 5 and 8 % caffeine for 20 days,
which were mixed well with larval food (Zeigler
AP100) and grinded to powder. At each time point, all
larvae in a tank were counted and harvested and killed
by tricane (Sigma) overdose. The length of zebrafish
was measured from tip of the nose to the end of body.
Larvae were wiped dry and weighed on a Mettler AE
50 balance to the nearest milligram.
Biochemical analyses of zebrafish lipids
Zebrafish larvae (n = 15–20 each) were homogenized
and diluted 10 times with double distilled water, cen-
trifuged and got supernatant liquid. Levels of total
cholesterols (TCH) and triglycerides (TGs) in the
supernatant were determined by Total Cholesterol
Reagent Kit and Triglyceride Reagent Kit (ZheJiang
DongGou Diagnostics Co.,LTD, China) according to
the manufacturer’s specification, respectively.
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Food intake of zebrafish larvae
20 dpf zebrafish larvae were allocated to normal feeding
and caffeine feeding group. Each group which have 15
larvae have a similar body weight and were fed with
20 mg food in 100 ml tanks. After feeding 2 h, the re-
mainder of food in water and on the bottom of tank
were collected, dried and weighted. Then the food intake
of 15 larvae was calculated by the feeding quantity
minus the remainder amount.
Whole-mount oil red O staining
Zebrafish larvae were fixed by 4 % paraformaldehyde so-
lution in PBS overnight 4 °C for 3 days, washed in PBS
and orderly immersed in 40, 60, 80 and 100 % 1,2-pro-
panediol at room temperature for 20 min respectively,
and then washed in PBS. Added fresh 0.5 % Oil Red O
solution, larvae were dyed at room temperature for 12 h,
and washed in PBS, and faded background color by add-
ing 100 % 1,2-propanediol. Stained larvae were stored in
80 % 1, 2-propanediol and then imaged with a bright-
field dissecting microscope (Olympus cellSens). Larvae
were defined as positive for steatosis if the boundary be-
tween liver and surrounding tissue is clear and more
than three lipid droplets were observed in the hepatic
paranchyma by staining.
Histologic assessment
Zebrafish were fixed using 4 % paraformaldehyde solu-
tion in PBS overnight at 4 °C, washed in PBS and equili-
brated in 30 % sucrose/PBS overnight at 4 °C. Then they
were embedded in OCT and cut using a cryostat for
8 μm section. Consecutive sections were paired on adja-
cent slides; one slide in each pair was stained with oil
red O and the other in hematoxylin and eosin (HE). For
frozen oil red O staining, after drying the sections were
immersed sequentially in 100, 85 % 1, 2 –propanediol
for 5 min. The sections were then immersed in a 0.5 %
Oil Red O (Sigma) solution for 2 h and rinsed with dis-
tilled water. Sections were then counterstained using
hematoxylin to visualize the nuclei. As for frozen HE
staining, the sections were treated sequentially to 100,
95, 90, 85, 80,70 % ethanol, and stained with hematoxy-
lin,washed in running tap water,stained with eosin,-
washed with running tap water, and mounted using
aqueous mounting media, Glycerin Jelly.
Quantitative real-time reverse transcriptase polymerase
chain reaction (qRT-PCR)
Total RNA samples from 20 zebrafish larvae liver were
used to generate cDNA using PrimeScriptTM RT reagent
Kit with gDNA Eraser (Perfect Real Time) (Takara, Japan).
QRT-PCR was done using a Roche LightCycler480 System
with FastStart Essential DNA Green Master (Roche,
USA). The thermal cycling condition comprised an initial
step at 95 °C for 1 min followed by 40 cycles of 95 °C for
10 s, 60 °C for 20 s and 72 °C for 30 s. The primers used
in this study are shown in Table 1. The mRNA level of
liver samples in all groups was normalized using expres-
sion of eukaryotic translation elongation factor 1 alpha 1,
like 1 (EFL1-alpha) as a housekeeping gene and was rela-
tive to control group according to the 2−ΔΔCT method.
Each sample was analysed in triplicate.
Western bloting
10–15 zebrafish larvae split from head to tail were lysed
on ice in RIPA buffer (Cell Signaling Technology) sup-
plemented with protease inhibitors (Roche). Quantified
protein lysates were separated on a 10 % SDS-PAGE
gels, electrotransferred onto polyvinylidene fluoride
(Millipore) membranes, blocked with 5 % bovine serum
albumin for 1 h at room temperature, and immunoblotted
with primary antibodies CHOP (G6916, Sigma) (1:400), BIP
(MB0050,Bioworld) (1:1000), IL-1β (16806-1-AP, Prointech)
(1:1000),β-actin (sc-8432, Santa Cruz Biotechnology)
(1:1000) overnight at 4 C. After the incubation with the cor-
responding secondary antibodies conjugated to horseradish
peroxidase, the signals of the membranes were detected by
enhanced chemiluminescence Western Blotting Substrate
(Pierce, Rockford). The band intensity of Western blot-
ting and the normalization were analyzed using the
ImageJ program (NIH, Bethesda,MD).
Statistics
All data are presented as means ± standard error of the
mean. These groups were tested for the effects of feeding
quantity, duration of feeding, and/or their interactions by
two-way analysis of variance. When the interaction and/or
the main effects were significant, the group means were
compared further using the Bonferroni’s multiple com-
parison tests. Differences between 2 groups were exam-
ined for statistical significance by Student’s t –test. For
multiple comparisons, one-way ANOVA followed by
Bonferroni-Dunn multiple-comparison procedure was
used. P < 0.05 was considered statistically significant. All
statistical analyses were performed using GraphPad Prism
5.00 for Windows (GraphPad, San Diego, CA, USA).
Results
Zebrafish larvae overfed diets remarkably developed
hepatic steatosis
Zebrafish have the feature of food preference. To under-
stand the association between the quantity and duration
of feeding and hepatic steatosis of zebrafish larvae, we ob-
served the changes of larval growth and hepatic steatosis
under different quantity and duration of feeding condi-
tions. Figure 1 shows that the body weight (Fig. 1a) and
length (Fig. 1b) of larvae does-dependently increased with
the increased amount of feeding, and the body weight of
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larvae fed for 20 days was significantly increased than that
fed for 15 days (Fig. 1a). Similarly, the body length of lar-
vae fed for 20 days was markedly increased than that fed
for 10 and 15 days (Fig. 1b). However, the mortality of lar-
vae between the different feeding groups had no signifi-
cant difference (Fig. 1c); The death rate of larvae fed for
15 and 20 days was significantly higher than that fed for
10 days, but it was not a significant change between larvae
fed for 15 and 20 days (Fig. 1c). The data suggested that
the mortality of larvae could be disassociated with the
amount of feeding and depend on inherent quality of zeb-
rafish larvae per se. The incidence of hepatic steatosis of
larvae was gradually increased with the increased amount
of feeding when estimated by whole-mount oil red O
(whole-mount ORO) staining, and it was 92.4 and 94.4 %
in larva fed on 120 mg and 180 mg per day for 20 days, re-
spectively (Fig. 1d). Then we evaluated the degree of hep-
atic steatosis of larvae in different quantity and duration
of feeding by using histological methods. The results of
whole-mount ORO and Frozen ORO and HE staining
showed that the liver in zebrafish larvae fed for 10 days
had lipid droplets accumulation (Fig. 2a) and the droplets
became more intensive and bigger when larva fed for 15
and 20 days (Fig. 2b,c). However, the liver in zebrafish lar-
vae fed 20 or 30 mg/d basically haven’t lipid accumulation,
indicating this amount of feeding can maintain the normal
need of energy for zebrafish larva. And the larvae fed 120
or 180 mg/d shown considerable lipid accumulation in the
liver, which suggested that in this condition zebrafish lar-
vae have surpassed the need of energy. Further, we exam-
ined the level of triglyceride (TG) and total cholesterol
(TCH) in zebrafish larvae. The results revealed that the
content of TG was significantly higher in larvae fed
180 mg/d (0.0142 ± 0.0011 mmol/gprotein) compared to
larvae fed 30 mg/d (0.0073 ± 0.0012 mmol/gprotein) for
20 days (Fig. 2d), and there was no difference in the level
of TCH between the two groups (Fig. 2d). Thus, these
data demonstrated that zebrafish larvae were quite readily
to have hepatosteatosis under the overfeed dietary condi-
tions and we successfully established an diet-induced
model of fatty liver in zebrafish larvae and provided a plat-
form for screening therapies drugs and studying mechan-
ism for NALFD.
Caffeine attenuated hepatic lipid accumulation in overfed
zebrafish larvae
Many epidemiological and clinical evidences have dem-
onstrated that coffee and caffeine have protective effects
on the chronic liver diseases. So we investigated whether
caffeine can reduce hepatic steatosis in overfeeding
zebrafish larvae or not. First, we evaluated the effect of
caffeine on the body weight of zebrafish. We found that
Table 1 Primer sequences used for quantitative real-time PCR (qPCR)
Gene Accession Forward primer Reverse primer
PPAR-γ DQ839547 5′-GGTTTCATTACGGCGTTCAC-3′ 5′-TGGTTCACGTCACTGGAGAA-3′
SREBP1 NM_001105129 5′-CATCCACATGGCTCTGAGTG-3′ 5′-CTCATCCACAAAGAAGCGGT-3′
PPAR-α NM_001102567 5′-CGTCGTCAGGTGTTTACGGT-3′ 5′-AGGCACTTCTGGAATCGACA-3′
ACC1 XM_009298360 5-′GCATAGGGCAGGTTTTACCA-3′ 5′-GCCATCATACGAGAGCAACA-3′
FASN XM_009306807 5-′GAGAAAGCTTGCCAAACAGG-3′ 5′-GAGGGTCTTGCAGGAGACAG-3′
CD36 NM_001002363 5′-AGGCCACTGTGAACCTGAAG-3′ 5′-AAGTTGGGGTTCATTCCGAC-3′
UCP2 NM_131176 5′-GAGCTTTGCTTCTGTACGCA-3′ 5′-ACGAAACCCCTCTTCCTTTG-3′
CPT I NM_001044854 5′-ACTCTCGATGGACCCTGTGA-3′ 5′-CTGGATGAAGGCATCTGGAC-3′
ACO NM_213147 5′-AAGGACATCGAGCGAATGAT-3′ 5′-CTATGAAAGAGTGGAGGCCG-3′
ATF6 NM_001110519 5′-CTGTGGTGAAACCTCCACCT-3′ 5′-CATGGTGACCACAGGAGATG-3′
IRE1 XM_009306258 5′-TGACGTGGTGGAAGTTGGTA-3′ 5′-ACGGATCACATTGGGATGTT-3′
PERK XM_005156585 5′-TGGGCTCTGAAGAGTTCGAT-3′ 5′-TGTGAGCCTTCTCCGTCTTT-3′
BIP NM_213058 5′-AAGAGGCCGAAGAGAAGGAC -3′ 5′-AGCAGCAGAGCCTCGAAATA -3′
CHOP XM_005166171 5′-AAGGAAAGTGCAGGAGCTGA -3′ 5′-TCACGCTCTCCACAAGAAGA- 3′
Beclin-1 NM_200872 5′-AGAGCATTGAGACAAAGCGTGAA -3′ 5′-TCTGCCAAGGCGGAAGTTATT-3′
ATG12 BC154046 5′-TTCATCTCACGCTTCCTCAA-3′ 5′-CGTCACTTCCGAAACACTCA-3′
ATG3 NM_200022 5-′GGCTGTTTGGATATGATGAG-3′ 5′-AGCAGGTGGAGGGAGATTAG- 3′
IL-1β AY340959 5′-TGGCGAACGTCATCCAAG-3′ 5′-GGAGCACTGGGCGACGCATA-3′
TNF-α AY427649 5′-GCTTATGAGCCATGCAGTGA-3′ 5′-TGCCCAGTCTGTCTCCTTCT-3′
NF-κB BC162402 5′-GAAGCATTCAGGCTCGGTGA-3′ 5′-CAGGTCTGTCGGTCCCTTTC-3′
EFL1-alpha AY422992 5′-TACTTCTCAGGCTGACTGTG-3 5′-ATCTTCTTGATGTATGCGCT-3′
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body weight of zebrafish was remarkably reduced in 2.5,
5 and 8 % caffeine groups compared with the model
group (180 mg/d), but there was no significant differ-
ence in 1 % caffeine group compared to the model group
(Fig. 3a). Meanwhile, the food intake of larvae have no
significant difference between normal feeding and 5 %
caffeine feeding group (Fig. 3b), suggesting that caffeine
have no influence on the appetite of zebrafish. As like
the body weight, the hepatic steatosis rate (Fig. 3c) and
the TG content (Fig. 3d) of zebrafish significantly de-
creased in 2.5, 5 and 8 % caffeine group and there was
no difference between 1 % caffeine and model group,
and the content of TCH have no significance between all
groups (Fig. 3e). Then frozen consecutive serial 8 μm
sections of a zebrafish larva in different groups were col-
lected on different slides, and one slide was stained with
hematoxylin and eosin (HE), while the other was stained
with oil red O (ORO) staining to observe lipid droplets.
The amount and size of lipid droplets in the liver of
zebrafish was markedly reduced in 2.5, 5 and 8 % caf-
feine group compared with 1 % caffeine and model
group (Fig. 4). Overall, our data showed that caffeine
can alleviate hepatic steatosis in overfed zebrafish larvae.
Caffeine got involved in modulating the expression of
genes associated with lipid metabolism
pathways,endoplasmic reticulum (ER) stress and hepatic
inflammatory cytokine
To investigate the mechanism by which caffeine re-
duced hepatic lipid accumulation, we examined the
expression levels of genes involved in lipid metabolism
(Fig. 5a). We first examined whether or not decreased
lipid accumulation in the liver of caffeine treatment
group occurred preferentially by dietary fat and uptake
through receptor-mediated endocytosis. The level of
gene expression of fatty acid transport protein exhib-
ited notably downregulation in 5 % caffeine group
compared with model group, including fatty acid
Fig. 1 Effects of quantity and duration of feeding on growth and incidence of hepatic steatosis and mortality of zebrafish larvae. Body weight (a)
and length (b) of zebrafish larvae were measured in different feeding groups for different feeding time (n = 80–91). c and d represent the effect
of the quantity of feeding on mortality and hepatic steatosis rate in zebrafish larvae fed for different feeding time, respectively (n = 3). Data are
expressed as mean ± SEM, **P < 0.01, ***P < 0.001
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Fig. 2 The liver histological changes of zebrafish larvae fed in different quantity of feeding and lipid contents in zebrafish. The
histological change of liver in zebrafish larvae fed for 10 (a), 15 (b), and 20 (c) days was analyzed using Whole-mount oil red O staining
(whole-mount ORO) (panels 1–6) (magnification × 32), frozen section oil red O staining (frozen ORO) (panels 7–12) (magnification × 400)
and H&E staining (panels 13–18) (magnification × 400). Red arrows indicate zebrafish liver, blue arrows indicate lipid droplets, black arrows
indicate vacuole lipid droplets. d Changes of triglyceride (TG) and total cholesterol (TCH) of zebrafish larvae fed for 20 days in 30 mg/d
and 180 mg/d feeding group, Data are represented as mean ± SEM, n = 3. **P < 0.01 by Student’s t test
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translocase (FAT)/CD36 (Fig. 5a). The mRNA levels of
uncoupling protein −2(UCP-2) and gene involved in
hepatic lipogenesis transcription factor as sterol regu-
latory element binding transcription factor 1(SREBP1)
was decreased. The level of gene expression of key
lipogenic enzymes involved in fatty acid synthesis was
significantly downregulated, including acetyl-CoA
carboxylase 1 (ACC1). Although the mRNA level of
fatty acid synthase (FASN) have no statistical differ-
ence between model group and caffeine treatment
Fig. 3 Effects of Caffeine on hepatic steatosis and lipid contents in overfed zebrafish larvae for 20 days. a The effects of caffeine on weight in
zebrafish larvae overfed for 20 days. n = 2 clutches per group, n = 79–86 per clutch. b The food intake of 15 larvae in normal feeding and 5 %
caffeine feeding group (n = 4). c Hepatic steatosis rate in zebrafish larvae overfed for 20 days (n = 3). The contents of triglyceride (d) and total
cholesterol (e) were measured in zebrafish larvae overfed with different concentration of caffeine for 20 days (n = 3). Data is expressed as
mean ± SEM. *P < 0.05, **P < 0.001, ***P < 0.001 by one-way ANOVA
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group, its level also reduced in zebrafish larvae fed on
5 % caffeine. But the mRNA level of gene acyl-CoA
oxidase (ACO) involved in fatty acid β-oxidation was
significantly increased in 5 % caffeine group (Fig. 5a).
Many evidences have exhibited that ER stress is in-
volved in the development of fatty liver and can pro-
mote the progression of NALFD. We explored
whether caffeine can impact on the function of ER to
perform protective effects on hepatocytes in overfed
zebrafish larvae (Fig. 5b). We found that the mRNA
level of genes involved in ER stress were significantly
upregulated in the liver of model group compared to
control group (30 mg/d), including IRE1, BIP, CHOP.
After caffeine treatment, the gene expression level of
IRE1 and BIP were decreased, and the mRNA level of
genes ATF6 and PERK were also remarkably reduced
in the liver of caffeine treatment larvae (Fig. 5b). Fur-
ther, western blot analysis showed that the level of Bip
and CHOP increased in model group compared to
control group and caffeine treatment resulted in a
marked reduction of the expression of them (Fig. 5e).
These results indicate that caffeine could improve ER
stress induced by overfeeding in zebrafish larvae.
Next, we examined the expression level of inflamma-
tory cytokine genes to confirm whether caffeine can
regulate inflammatory response. As Fig. 5c showed
that the inflammatory cytokines, including IL-1beta
and TNF-alpha, were markedly increased in the liver
of model group compared with control group. The
mRNA level of IL-1beta and TNF-alpha were signifi-
cantly decreased in 5 % caffeine group compared to
model group. The protein level of IL-1beta also de-
creased in caffeine treatment group as evidenced by
western blot (Fig. 5f ). No significant difference was
observed in the expression of NF-κB. In addition, the
mRNA level of ATG12 and Beclin-1, which is impli-
cated in autophagy, were significantly decreased in the
liver of 5 % caffeine treatment group (Fig. 5d). Taken
together, these results indicated that caffeine may in-
hibit lipogenesis and lipid transport, and increase lipid
oxidation, and probably improve ER stress and reduce
hepatic inflammatory response to ameliorate hepatic
lipid accumulation in zebrafish larvae.
Discussion
In present study, we examined the efficacy of caffeine
in fatty liver zebrafish larvae via successful establish-
ment of a diet-induced zebrafish larva model for
NAFLD. Our results demonstrated that juvenile zeb-
rafish is readily to be induced to pronounced hepatic
lipid accumulation undergoing an overfeeding regimen
for 20 days. The rate of hepatic steatosis could reach
Fig. 4 Effects of caffeine on hepatic lipid accumulation in zebrafish larvae overfed for 20 days. Frozen section hematoxylin and eosin staining
(Frozen H&E) of liver sections in 30 mg/d (a), 180 mg/d (b), 1 % caffeine (c), 2.5 % caffeine (d), 5 % caffeine (e), and 8 % caffeine (f) feeding
zebrafish larvae. Black arrow indicate lipid droplet. Frozen Oil red O staining (Frozen ORO) of liver sections in 30 mg/d (g), 180 mg/d (h), 1 %
caffeine (i), 2.5 % caffeine (j), 5 % caffeine (k), and 8 % caffeine (l) feeding zebrafish larvae. Blue arrow indicate lipid droplet
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up to 90 % in overfed zebrafish larvae. In addition,
we demonstrated that caffeine can attenuate hepatic
lipid accumulation in diet-induced fatty liver zebrafish
through inhibition of fatty acid uptake and lipogenesis
and improvement of ER function, and attenuation of
inflammation response.
As a new model of studying human diseases, zebrafish
have got more and more attentions for researchers in
the pathogenesis of investigating human conditions and
drugs screening, the main causes of which is that zebra-
fish possess plenty of merits such as the similarity of its
genome with humans, the tractability of its genetics,
Fig. 5 Effects of caffeine on the expression of selected genes in livers of zebrafish larvae overfed for 20 days. The relative mRNA expression of
genes involved in lipid metabolism (a), ER stress (b), inflammatory factors (c), and autophage (d) in control (30 mg/d) and 5 % caffeine group
compared with gene expression in model group (180 mg/d) by qRT-PCR. Expression analysis of the selected genes using cDNA prepared from
liver of zebrafish larvae (n = 20) in each group. Data is expressed in mean ± SEM, n = 5. Protein expression of ER stress (e) and inflammatory factor
(f) was examined by western blot in caffeine treatment and model group zebrafish larvae. * P < 0.05, * *P < 0.01, * * *P < 0.001 by one-way ANOVA
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short breeding period, and low cost and convenience of
feeding. Many studies have reported that zebrafishes
were exploited to identify the molecular mechanisms of
nonalcoholic fatty liver diseases [11, 13, 14, 40, 41] and
performed associated drugs screening [42–44], which
shows the great value of its application in human dis-
eases. This study shown that zebrafish larvae in juvenile
have significant lipid accumulation in the liver over the
increasing quantity and duration of feeding via the ob-
servation of morphological and histological methods in
zebrafish. The percentage of hepatic steatosis of zebra-
fish larvae reached up to 90 % in the groups fed on
120 mg/d or 180 mg/d for 20 days, and Whole-mount
oil red O staining and HE staining showed that macro-
vesicular lipid droplets presented in liver after fish fed
for 20 days. However, zebrafish larvae fed with 20 mg/d
or 30 mg/d hardly have lipid droplets in liver and there
is no significant difference in the mortality of larvae be-
tween all groups. The level of triglyceride of larvae in
the model group is significantly higher than that in the
controlg group, and the mRNA level of inflammatory cy-
tokines IL-1beta and TNF-alpha are upregulated in the
model group. These data suggested that zebrafish larvae
are readily to develop fatty liver and have a trend toward
the progression of NASH under the overfeeding condi-
tions (180 mg/d). Considering that zebrafish are in the
period of growth and development and the prevalence of
NAFLD in children and adolescent is increasing at
present, this model provides an opportunity and refer-
ence for studying NAFLD in children and adolescent.
We demonstrated that caffeine can reduce hepatic lipid
accumulation in zebrafish, which was coordinated with
the results of previous researchers studying the effects of
caffeine in human [27, 29], rats [38] and hepatocytes [39].
Although caffeine displayed the does-dependence associ-
ation with reduced lipid level of HepG2 cell in vitro [39],
this relationship was not observed in our study in zebra-
fish. Many studies have demonstrated that caffeine exist
the effect of anti-obesity through reduction of the size of
adipose tissue and amount of adipocytes [45, 46] and in-
crease of heat production of adipose tissue and the basal
metabolic rate of body [47] in mice. Moreover, in vitro
study suggested that caffeine can inhibit the development
and differentiation of adipocyte through inhibition of adi-
pogenic related factors [48]. These roles of caffeine maybe
explain the reduction of body weight in caffeine treatment
zebrafish in our research. However, further researches are
required to investigate whether caffeine have the role of
inhibition of development and differentiation of adipocyte
in vivo. Our data shown that low concentration of caffeine
(<1 %) didn’t change lipid accumulation in liver of zebra-
fish and moderate concentration of caffeine (2.5–8 %) ex-
hibited the antisteatotic effect, which was consistent with
epidemiological and clinical evidences that moderate
caffeine intake have a hepatoprotective effect on NAFLD
and fibrosis/cirrhosis [34, 49] with consumption of more
than three cups of coffee per day. The mortality of larvae
markedly increased when caffeine concentration reached
up to 10 % (data not shown), indicating that high concen-
tration caffeine may present toxicity in zebrafish larvae
probably because of the induction of cell apoptosis in high
caffeine concentration [50–52]. So maybe it is a good ad-
vice to drink a moderate coffee in daily life.
Regarding to the molecular mechanism of caffeine al-
leviating hepatic lipid accumulation, we determined the
expression of genes associated with lipid metabolism.
Our results shown downregulation of transcription fac-
tor SREBP1, which control the lipogenesis transcription-
ally, and its downstream genes ACC1 and FASN that are
key enzymes in the lipid synthesis, and upregulation of
ACO gene which involve in lipid beta-oxidation. This re-
sult is consistent with previous findings of Hai Yan Quan
[39], suggesting that caffeine can inhibit de novo lipo-
genesis and enhance lipid oxidation in liver. Fatty acid
translocase (FAT/CD36) is a membrane protein partici-
pated in fatty acid intake of hepatocytes. Clinical evi-
dence have demonstrated that CD36 is significantly
increased in fatty liver and NASH patients [53], indicat-
ing of the association of the development of NAFLD
with increased input of fatty acid in hepatocytes. Our
data exhibited the reduced mRNA level of CD36 in caf-
feine treatment larvae, demonstrating that caffeine may
be exert antisteatotic effect through reduction of fatty
acid uptake. Endoplasmic reticulum (ER) stress is an
adaptive response due to excessive accumulation of un-
folded responsive protein in cells. There have numerous
evidences that ER stress can contribute to fatty liver,
promote the progression of NASH [54] and the develop-
ment of obesity,and activate the inflammatory signalling
pathway mediated by NF-κB-IκB kinase (IKK) and JNK
signalling [55, 56]. Recent reports have shown that caf-
feine can improve leptin-resistance of neuron by reduced
ER stress via attenuation of activation of IRE-1 and
PERK [57] and that coffee can show anti-injury role by
reducing the level of IL-6 and TNF-alpha in the Long-
Evans Cinnamon rat [58]. In present study, we found
that caffeine markedly reduced expression of genes asso-
ciated with ER stress including IRE-1, PERK, ATF6,
CHOP and BIP, indicating that caffeine may improve ER
stress to protect liver cell. Simultaneously, caffeine also
decreased the expression level of inflammatory cytokines
such as IL-1beta and TNF-alpha. This is likely to be
caused by improvement of ER stress, because ER stress
can activate the signalling pathway of inflammation re-
sponse. Although our data shown that caffeine may have
an effect on enhancement of the adaptive ability of zeb-
rafish in response to stress at the level of transcription,
there need more studies to research the precise
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molecular mechanism by which caffeine exert hepato-
protective effect in NAFLD.
Conclusions
The present experiment shows that zebrafish larvae are
quite readily to develop hepatic steatosis by the overfeed-
ing regimen. We demonstrated that caffeine have an anti-
steatotic and hepatoprotective effect on fatty liver in
zebrafish, maybe through reduction of fatty acid uptake
and lipogenesis, enhancement of lipid beta-oxidation, im-
provement of ER stress and attenuation of inflammation
response. Thus caffeine can become a potential drug for
NAFLD treatment and zebrafish model of NAFLD provide
a cost and convenient platform for drug screening.
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